Etiology and Prognostic Factors in Patients With Acute Liver Failure

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLi-Ying Sun

About this trial

Acute liver failure (ALF) is a rare but life-threatening condition with high mortality. Despite advances in supportive care and liver transplantation, prognosis varies significantly across etiologies, particularly in patients with indeterminate causes.

This study aims to investigate the dynamic changes of clinical and biochemical indicators, identify potential etiologies-especially in indeterminate ALF-and evaluate prognostic risk factors. A dynamic prediction model will be developed to optimize clinical decision-making, including liver transplantation timing.

Both retrospective and prospective cohorts will be included. Multi-omics analyses (including transcriptomics, proteomics, metabolomics, and metagenomic sequencing) will be performed on liver tissue and biological samples to explore disease mechanisms and etiology.

Eligibility criteria

Qualifiers

Patients (or guardians) who provide informed consent

Disqualifiers

Presence of end-stage extrahepatic disease without effective treatment

Pregnant or breastfeeding women

Inability or unwillingness to provide informed consent or comply with study procedures

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 3 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Li-Ying Sun

Lead sponsor

Beijing Friendship Hospital

Sponsor institution